Zyomyx, Inc.

Zyomyx Inc. is an innovator and leader in the development and commercialization of proprietary protein analysis platforms, with 6+ years of product development experience in protein biochips and biointerface technologies. With varied technology assets and a proven R&D core expertise in biochemistry, materials science and microsystem technologies, Zyomyx is entering development agreements primarily aimed at providing its clients with marketable products and technologies. In addition, Zyomyx offers its existing product line of protein profiling bioassays to new and existing customers through a streamlined service model.Since its founding in 1998, Zyomyx has also been pursuing an aggressive intellectual property strategy. The rich portfolio of more than 120 pending and issued patents is constantly being expanded and also provides a broad platform enabling our development partners to market and protect their products as well as to develop new products in cooperation with Zyomyx.Zyomyx has an extended knowledge base focused on areas including proteomics, molecular diagnostics, medical devices and industrial applications where the company's unique surface science and biointerface capabilities are key elements in next generation products. The infrastructure at Zyomyx includes state-of-the-art R&D facilities, a sophisticated analytical instrumentation suite as well as a fully operational biochip manufacturing line.

Contact Details: 26101 Research Road Hayward California 94545 United States of America Tel: 510 265 8000 Fax: 510 784 2569 Email: info@zyomyx.com WWW: www.zyomyx.com/

Loading...

Press Releases on Zyomyx, Inc.:
Zyomyx Point-of-Care CD4 Test Selected by CD4 Initiative to Help Treat HIV/AIDS Patients in Developing Countries	17th November, 2009	Zyomyx, Inc.	HAYWARD, Calif., Nov. 17 /PRNewswire/ -- Zyomyx, Inc., a leader in chip-based bioanalysis technologies, today announced that its readerless CD4 point-of-care (POC) technology was selected by Imperial

BioNews Results for Zyomyx, Inc.:
Adherex Technologies Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report	PR inside:  Nov 16 2009 7:07AM Matching: inc
Guru Stocks at 52-Week Low: Genzyme Corp, Apollo Group Inc, Ralcorp Holdings Inc, Aqua America Inc, MetroPCS C	Guru Focus:  Nov 16 2009 3:51AM Matching: inc
AngioDynamics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released	PR inside:  Nov 16 2009 5:28AM Matching: inc
Advaxis, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released	PR inside:  Nov 16 2009 7:02AM Matching: inc
Alcon, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released	PR inside:  Nov 16 2009 6:25AM Matching: inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more Zyomyx, Inc. news.

Zyomyx, Inc. Patents:
US Patent No.	Title
7438856	Microfluidic devices and methods
6576478	Microdevices for high-throughput screening of biomolecules
6582969	Microdevices for high-throughput screening of biomolecules
6596545	Microdevices for screening biomolecules
6682942	Microdevices for screening biomolecules
→View more Zyomyx, Inc. patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1143 times since April 2007, the link to the organisation's website has been followed 166 times

Recent Search Terms used to find this page: zyomyx inc | zyomyx inc | zyomyx | zyomyx | zyomyx | zyomyx | zyomyx | .

Search for more companies in Hayward

Search for more companies in California

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Zyomyx, Inc.